SCD and non-small cell lung carcinoma: In NSCLC cell lines and patient tissues, tyrosine kinase inhibitor (gefitinib) resistant cells had more LDs compared to their sensitive controls with greater expression of stearoyl-CoA desaturase 1 (SCD1) (Huang et al., 2019).